{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T04:48:00Z","timestamp":1787287680881,"version":"build-2736575974"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.jpba.2025.116884","type":"journal-article","created":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T16:42:44Z","timestamp":1744303364000},"page":"116884","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["A convenient and rapid LC-MS\/MS method for determination of free and liposomal amphotericin B in human plasma by simultaneous separation using SPE"],"prefix":"10.1016","volume":"262","author":[{"given":"Yi","family":"Jin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bowen","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuting","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huanyu","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruihan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.jpba.2025.116884_bib1","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1046\/j.1365-2710.1999.00220.x","article-title":"A comparative review of conventional and lipid formulations of amphotericin B","volume":"24","author":"Robinson","year":"1999","journal-title":"J. Clin. Pharm. Ther."},{"issue":"9","key":"10.1016\/j.jpba.2025.116884_bib2","first-page":"461","article-title":"Pharmacokinetic characterization of liposomal amphotericin B: investigation of clearance process and drug interaction potential","volume":"59","author":"Matsui","year":"2009","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.jpba.2025.116884_bib3","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.cbi.2016.06.022","article-title":"In vitro evaluation of antifungal and cytotoxic activities as also the therapeutic safety of the oxidized form of amphotericin B","volume":"256","author":"Klimek","year":"2016","journal-title":"Chem. Biol. Inter."},{"issue":"1","key":"10.1016\/j.jpba.2025.116884_bib4","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1093\/jac\/49.suppl_1.37","article-title":"Amphotericin B. nephrotoxicity","volume":"49","author":"Deray","year":"2002","journal-title":"J. Antimicrob. Chemother."},{"issue":"1","key":"10.1016\/j.jpba.2025.116884_bib5","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1093\/jac\/dkh025","article-title":"Study of the toxicity of a new lipid complex formulation of amphotericin B","volume":"53","author":"Larabi","year":"2004","journal-title":"J. Antimicrob. Chemother."},{"issue":"B","key":"10.1016\/j.jpba.2025.116884_bib6","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1093\/jac\/28.suppl_B.83","article-title":"Liposomal amphotericin B (AmBisome): safety data from a phase II\/III clinical trial","volume":"28","author":"Meunier","year":"1991","journal-title":"J. Antimicrob. Chemother."},{"issue":"6","key":"10.1016\/j.jpba.2025.116884_bib7","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/S1461-5347(99)00160-1","article-title":"Lipid-based amphotericin B formulations: from animals to man","volume":"2","author":"Bekersky","year":"1999","journal-title":"Pharm. Sci. Technol. Today"},{"issue":"5","key":"10.1016\/j.jpba.2025.116884_bib8","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1086\/317451","article-title":"A randomized, double-blind comparative trial evaluating the safety of liposomal amphotericin B versus amphotericin B lipid complex in the empirical treatment of febrile neutropenia","volume":"31","author":"Wingard","year":"2000","journal-title":"L Amph\/ABLC Collab. Study Group, Clin. Infect. Dis."},{"issue":"4","key":"10.1016\/j.jpba.2025.116884_bib9","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s40265-016-0538-7","article-title":"Liposomal Amphotericin B (AmBisome\u00ae): a review of the pharmacokinetics, pharmacodynamics, clinical experience and future directions","volume":"76","author":"Stone","year":"2016","journal-title":"Drugs"},{"issue":"3","key":"10.1016\/j.jpba.2025.116884_bib10","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1128\/AAC.46.3.828-833.2002","article-title":"Pharmacokinetics, excretion, and mass balance of liposomal amphotericin B (AmBisome) and amphotericin B deoxycholate in humans","volume":"46","author":"Bekersky","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"issue":"11","key":"10.1016\/j.jpba.2025.116884_bib14","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1111\/j.2042-7158.1996.tb03904.x","article-title":"Comparative study of separation of non-encapsulated drug from unilamellar liposomes by various methods","volume":"48","author":"Dipali","year":"1996","journal-title":"J. Pharm. Pharm."},{"issue":"2","key":"10.1016\/j.jpba.2025.116884_bib15","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1006\/abio.1995.0001","article-title":"Determination of free and liposome-associated doxorubicin and vincristine levels in plasma under equilibrium conditions employing ultra\ufb01ltration techniques","volume":"232","author":"Mayer","year":"1995","journal-title":"Anal. Biochem."},{"issue":"3","key":"10.1016\/j.jpba.2025.116884_bib16","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1097\/00007691-200106000-00015","article-title":"Quantitation of free and total amphotericin B in human biologic matrices by a liquid chromatography tandem mass spectrometric method","volume":"23","author":"Lee","year":"2001","journal-title":"Ther. Drug. Monit."},{"key":"10.1016\/j.jpba.2025.116884_bib17","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2021.782131","article-title":"Sensitive LC-MS\/MS methods for amphotericin b analysis in cerebrospinal fluid, plasma, plasma ultrafiltrate, and urine: application to clinical pharmacokinetics","volume":"9","author":"Pippa","year":"2021","journal-title":"Front. Chem."},{"issue":"2","key":"10.1016\/j.jpba.2025.116884_bib18","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0378-4347(01)00292-4","article-title":"Determination of amphotericin B, liposomal B, and amphotericin B colloidal dispersion in plasma by high-performance liquid chromatography","volume":"760","author":"Egger","year":"2001","journal-title":"J. Chromatogr. B Biomed. Sci. Appl."},{"issue":"3","key":"10.1016\/j.jpba.2025.116884_bib19","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1016\/S0022-3565(24)29494-5","article-title":"Liposomal and nonliposomal drug pharmacokinetics after administration of liposome-encapsulated vincristine and their contribution to drug tissue distribution properties","volume":"298","author":"Krishna","year":"2001","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"3-4","key":"10.1016\/j.jpba.2025.116884_bib20","first-page":"315","article-title":"Determination of free and liposomal amphotericin B in human plasma by liquid chromatography-mass spectroscopy with solid phase extraction and protein precipitation techniques","volume":"878","author":"Deshpande","year":"2010","journal-title":"J. Chromatogr. B Biomed. Sci. Appl."},{"key":"10.1016\/j.jpba.2025.116884_bib21","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.jpba.2018.06.014","article-title":"Bioanalysis of free and liposomal amphotericin B in rat plasma using solid phase extraction and protein precipitation followed by LC-MS\/MS","volume":"158","author":"Su","year":"2018","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2025.116884_bib22","first-page":"149","article-title":"Determination of non-liposomal and liposomal doxorubicin in plasma by LC\u2013MS\/MS coupled with an effective solid phase extraction: in comparison with ultra\ufb01ltration techniques and application to a pharmacokinetic study","volume":"1072","author":"Xie","year":"2018","journal-title":"J. Chromatogr. B Biomed. Sci. Appl."},{"issue":"6","key":"10.1016\/j.jpba.2025.116884_bib23","first-page":"687","article-title":"The development of a method to quantify total and free irinotecan and 7-ethy-10-hydroxycamptothecin (SN-38) for pharmacokinetic and bio-distribution studies after administration of irinotecan liposomal formulation","volume":"14","author":"Yang","year":"2019","journal-title":"Asian J. Pharm. Sci."},{"key":"10.1016\/j.jpba.2025.116884_bib24","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jpba.2019.03.034","article-title":"A validated UPLC-MS\/MS method to determine free and total irinotecan and its two metabolites in human plasma after intravenous administration of irinotecan hydrochloride liposome injection","volume":"170","author":"Zhuang","year":"2019","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2025.116884_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2020.113388","article-title":"Direct quantitation of free, encapsulated, total doxorubicin and doxorubicinol in stabilized frozen human plasma to support a BE study of liposomal doxorubicin","volume":"189","author":"Ji","year":"2020","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"7","key":"10.1016\/j.jpba.2025.116884_bib26","doi-asserted-by":"crossref","first-page":"421","DOI":"10.4155\/bio-2021-0281","article-title":"Regulated bioanalysis of liposomal amphotericin B to support pharmacokinetic studies of liposomal drugs","volume":"14","author":"Zhang","year":"2022","journal-title":"Bioanalysis"},{"issue":"1-2","key":"10.1016\/j.jpba.2025.116884_bib29","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S0021-9673(02)01440-1","article-title":"Determination of free and liposome-associated daunorubicin and daunorubicinol in plasma by capillary electrophoresis","volume":"979","author":"Griese","year":"2002","journal-title":"J. Chromatogr. A."},{"issue":"1","key":"10.1016\/j.jpba.2025.116884_bib30","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0003-2697(90)90528-H","article-title":"Method for rapid separation of liposome-associated doxorubicin from free doxorubicin in plasma","volume":"188","author":"Thies","year":"1990","journal-title":"Anal. Biochem."}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708525002250?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708525002250?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T20:20:51Z","timestamp":1753388451000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708525002250"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":25,"alternative-id":["S0731708525002250"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2025.116884","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A convenient and rapid LC-MS\/MS method for determination of free and liposomal amphotericin B in human plasma by simultaneous separation using SPE","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2025.116884","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"116884"}}